Cell Signaling Technology

alpha/beta-Tubulin Antibody

#2148 · $314

100
Citing papers
19.8k
Combined citations
Supplier page Find this product

Research areas

Cancer Immunotherapy and Biomarkers6Adipose Tissue and Metabolism6Metabolism, Diabetes, and Cancer5Autophagy in Disease and Therapy5Cytokine Signaling Pathways and Interactions5Immune Response and Inflammation5Extracellular vesicles in disease5MicroRNA in disease regulation5

Papers citing this product

1
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Cell·2010·1.5k cit.·DOI
2
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
The Journal of Experimental Medicine·2015·1.1k cit.·DOI
3
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
Nature Communications·2016·657 cit.·DOI
4
FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end–directed vesicle transport
The Journal of Cell Biology·2010·639 cit.·DOI
5
Network Properties of Robust Immunity in Plants
PLoS Genetics·2009·623 cit.·DOI
6
ATF3 Increases the Intrinsic Growth State of DRG Neurons to Enhance Peripheral Nerve Regeneration
Journal of Neuroscience·2007·426 cit.·DOI
7
Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
Nature Communications·2020·374 cit.·DOI
8
Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-κB Ligand (RANKL)-induced JNK Activation
Journal of Biological Chemistry·2001·355 cit.·DOI
9
Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency
Journal of Biological Chemistry·2005·346 cit.·DOI
10
Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB
Scientific Reports·2014·340 cit.·DOI
alpha/beta-Tubulin Antibody — Evidence — PubIndex